Hims & Hers Health, Inc.
HIMS- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001773751
In the last 90 days, Hims & Hers Health, Inc. insiders filed 0 open-market purchases and 14 sales; 506 institutions reported holding it in 13F filings for Q2 2026, worth $5.39B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Hims & Hers Health, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 139 | 132 | −7 |
| Shares | 70.0M | 78.5M | +8.40M (+12.0%) |
| Value | $458.7M | $418.1M | −$40.7M (−8.9%) |
New holders (20)
Institutions that held Hims & Hers Health, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| NewView HMS SPV Partners, LLC | 9,663,356 | $51.5M | 100.00% |
| Landscape Capital Management, L.L.C. | 550,659 | $2.94M | 0.37% |
| Schonfeld Strategic Advisors LLC | 231,731 | $1.24M | 0.01% |
| Ergoteles LLC | 178,000 | $949.0K | 0.04% |
| Catalyst Capital Advisors LLC | 120,000 | $640.0K | 0.03% |
| Quantbot Technologies LP | 98,447 | $524.0K | 0.05% |
| Russell Investments Group, Ltd. | 47,000 | $250.0K | 0.00% |
| Legacy Advisors, LLC | 32,026 | $171.0K | 0.03% |
| Pathstone Family Office, LLC | 30,967 | $165.0K | 0.00% |
| Virtu Financial LLC | 18,222 | $97.0K | 0.01% |
| Diametric Capital, LP | 15,194 | $80.0K | 0.04% |
| Intellectus Partners, LLC | 10,200 | $54.0K | 0.02% |
| Sciencast Management LP | 10,600 | $53.0K | 0.01% |
| Leonteq Securities AG | 6,000 | $32.0K | 0.00% |
| State of Wyoming | 3,028 | $16.0K | 0.01% |
| Geneos Wealth Management Inc. | 2,150 | $11.0K | 0.00% |
| Quent Capital, LLC | 491 | $3.00K | 0.00% |
| Barclays PLC | 361 | $2.00K | 0.00% |
| Prospera Financial Services Inc | 312 | $2.00K | 0.00% |
| Raleigh Capital Management Inc. | 31 | $0 | 0.00% |
Sold out (27)
Institutions that held Hims & Hers Health, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.